Rare diseases affect millions of individuals worldwide, yet the complexity of researching these conditions makes global trials both essential and ethically challenging. With small, dispersed patient populations, high stakes for treatment, and diverse regulatory environments, rare disease trials require ethical rigor at every stage. Upholding integrity and fairness is not...